Jemperli, a cancer drug manufactured by GlaxoSmithKline, improved survival for patients diagnosed with a form of uterine cancer by more than one year, the British drugmaker said Saturday, the latest findings of a late-stage trial by GSK seeking to expand the use of the treatment.
The findings—part of a late-stage trial by the drugmaker—also indicated treatment resulted in a 31% and 37% reduction in risk of death and risk of disease progression, respectively, when compared with just chemotherapy treatment, the drugmaker said.to use with chemotherapy for treating some types of endometrial cancer, which forms in the womb, that are in advanced stages or have returned.
Health Health Latest News, Health Health Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: NBCNewsHealth - 🏆 707. / 51 Read more »
Tenure Track (Cancer Research) - Peoria, Illinois job with University of Illinois College of Medicine at PeoriaHiring Department: UICOMP-CBP Location: Peoria, IL USA Requisition ID: 1023695 Posting Close Date: 4/15/2024 The Department of Cancer Biology and Pharmacology of the University of Illinois College of Medicine at Peoria (UICOMP) is now inviting applications for tenure-track Assistant/Associate Professor level positions to expand its...
Source: NatureMedicine - 🏆 451. / 53 Read more »
Boyi Gan lab - Houston, Texas (US) job with The University of Texas MD Anderson Cancer CenterNew postdoctoral positions are open in a cancer research laboratory located within The University of Texas MD Anderson Cancer Center.
Source: Nature - 🏆 64. / 68 Read more »
Source: FOX10Phoenix - 🏆 83. / 68 Read more »